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ABSTRACT: Cytotoxicity screenings have identified Plectranthus
plants as potential sources of antitumor lead compounds. In this
work, several extracts from Plectranthus madagascariensis were
prepared using different solvents (acetone, methanol, and
supercritical CO2) and extraction techniques (maceration, ultra-
sound-assisted, and supercritical fluid extraction), and their
chemical composition was detailed using high-performance liquid
chromatography with a diode array detector. The cytotoxic activity
of the major compounds identified, namely, rosmarinic acid (1)
and abietane diterpenes 7α,6β-dihydroxyroyleanone (2), 7α-
formyloxy-6β-hydroxyroyleanone (3), 7α-acetoxy-6β-hydroxyroy-
leanone (4), and coleon U (5), was evaluated in a battery of
human cancer cell lines, including breast (MDA-MB-231, MCF-7),
colon (HCT116), and lung (NCI-H460, NCI-H460/R) cancer,
and also in healthy lung (MCR-5) cells. Royleanone (3) was isolated for the first time from P. madagascariensis, and its full
spectroscopic characterization (proton and carbon nuclear magnetic resonance) was accomplished. A high selectivity for lung
cancer cells was observed for royleanones (2, 4) with selectivity indexes of 4.3 and 3.2, respectively. The observed results
combined with literature data allowed the establishment of important structure−activity relationships for substituted royleanone
abietanes, such as the requirement for an electron-donating group at positions 6 and/or 7 in the abietane skeleton, and an
improved cytotoxic effect for substituents with log P values between 2 and 5.
■ INTRODUCTION
Plectranthus species have been traditionally used for a wide
range of complaints,1 mainly of the respiratory system,
gastrointestinal tract, nervous system, skin disorders, infections,
pain, and different types of cancer due to their medicinal
properties, which include antimicrobial,2−5 antioxidant,3,6 anti-
inflammatory,7,8 and cytotoxic7−11 activities. Several cytotoxic
activity studies have been performed on Plectranthus spp.
Cytotoxicity screening of South African medicinal plants
traditionally used in the treatment or prevention of cancer12
revealed that the extracts of Plectranthus ciliatus and
Plectranthus barbatus inhibited the growth of both sensitive
CCRF-CEM and multidrug-resistant CEM/ADR5000 leuke-
mia cells. Similarly, in another in vitro screening using the
RBL-2H3 cell line,8 P. ciliatus showed higher cytotoxicity
among the acetone extracts of the seven Plectranthus species
tested.
The organic extracts of Plectranthus amboinicus also exhibit
relevant cytotoxicity. The ethyl acetate extract inhibited the
growth of breast cancer MCF-7 cells,13 whereas the ethanol
extract suppressed growth and induced apoptosis in the human
lung cancer A549 cell line.14 Moreover, the hydroalcoholic
extract from leaves of P. amboinicus showed interesting in vivo
antitumor effects.7 On the other hand, the ethanol extract from
aerial parts of Plectranthus neochilus has shown cytotoxic effects
in the Artemia salina model,15 and more recently, a hexane
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extract showed growth inhibitory effects in cell carcinoma cell
lines.16
The promising results from the screening of Plectranthus
extracts followed by the bio-guided isolation of the active
compounds led to the elucidation of some promising
anticancer lead compounds, namely, labdane and abietane
diterpenes. The labdane diterpene forskolin, isolated from the
roots of P. barbatus, was one of the first compounds isolated
from Plectranthus species with promising anticancer activity.17
Furthermore, forskolin was shown to be a potent inhibitor of
the growth of colon cancer cells with induction of cycle arrest
at the G1 phase and further apoptosis.
18
Abietane diterpenes of the royleanone and coleon type
commonly found in the Plectranthus genus, as well as other
abietanoid quinone methides, such as Parvifloron D isolated
from Plectranthus ecklonii,9 have been described as potent
antiproliferative and/or cytotoxic agents.9−11,19−21
Previous cytotoxicity activity screening performed by our
group from Plectranthus madagascariensis, P. neochilus, and
Plectranthus porcatus revealed promising cytotoxic activity of
the P. madagascariensis extract obtained by maceration in
acetone and in the MDA-MB-231 breast cancer cell line,24
encouraging further research. In this study, the chemical
composition of several P. madagascariensis extracts obtained
using different organic solvents and extraction methodologies
was detailed using high-performance liquid chromatography
with a diode array detector (HPLC-DAD) and complementary
spectroscopic methodologies, and the major compounds were
identified and quantified. The cytotoxic effects of the pure
compounds were evaluated in human breast, lung, and colon
cancer cell lines, and relevant structure−activity relationships
were disclosed for the royleanone-type abietane diterpenes.
■ RESULTS AND DISCUSSION
Preparation of P. madagascariensis Extracts. Several
extracts from P. madagascariensis have been prepared using
different solvents (acetone, methanol, and supercritical CO2)
and extraction techniques (maceration, ultrasound-assisted,
and supercritical fluid extraction), resulting in different
extractive yields (Table 1).
Higher extractive yields were obtained using methanol as the
solvent, which can be due to the ability of alcohol to disrupt
the plant cell wall favoring the diffusion of secondary
metabolites to the bulk extract. Moreover, considering the
relative polarity of the extraction solvents in terms of dielectric
constant (ε), a trend was observed for the more polar solvents
to achieve higher extraction yields (εmethanol > εacetone≫ εscCO2).
The supercritical fluid extraction (SCFE) method using scCO2
was the least efficient extraction process with the lower yield.
Because of this low extraction efficiency, a re-extraction of the
remaining plant material with acetone was performed to extract
the remaining secondary metabolites, which resulted in a
higher extraction yield (E6, Table 1) when compared to SCFE
alone.
HPLC-DAD Extract Profiling. The identification and
quantification of major compounds (rosmarinic acid (1),
6β,7α-dihydroxyroyleanone (2), 7α-formyloxy-6β-hydroxyroy-
leanone (3), 7α-acetoxy-6β-hydroxyroyleanone (4), and
coleon U (5); Figure 1) in P. madagascariensis extracts were
performed using HPLC-DAD and complementary spectro-
scopic methodologies.
Previous phytochemistry studies on the Plectranthus genus
revealed the presence of polyphenols and diterpenes as the
most frequent secondary metabolites.3,6,32 These compounds
have characteristic absorption patterns in the UV spectral
region due to the presence of conjugated carbonyl groups (270
Table 1. Preparation, Yields, and Component Quantification of P. madagascariensis Extracts
component yield in extract (mg/g)b
extract solvent methoda extraction yield (mg/g) (1) (2) (3) (4) (5)
E1 acetone UAE 1.51 29.8 4.62 1.64 1.04 15.5
E2 acetone ME 1.45 17.5 3.19 6.74 1.21 5.77
E3 methanol UAE 6.56 4.60 4.20 0.81 0.77 t
E4 methanol ME 12.0 26.4 1.05 0.24 t t
E5 scCO2 SCFE 1.31 17.8 4.98 0.20 0.84 n/d
E6 acetone R-SCFE 2.95 50.5 0.33 0.17 n/d n/d
aUAE, ultrasound-assisted extraction; ME, maceration extraction; SCFE, supercritical fluid extraction; R-SCFE, re-extraction of SCFE remaining
plant material. bt, traces. n/d not detected. The extraction yield is express in mg of extract per g of plant dry material. The component yield is
express in mg of component per g of plant dry material.
Figure 1. Chemical structure of the major components in P. madagascariensis extracts: rosmarinic acid (1), 6β,7α-dihydroxyroyleanone (2), 7α-
formyloxy-6β-hydroxyroyleanone (3), 7α-acetoxy-6β-hydroxyroyleanone (4), and coleon U (5).
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nm), aromatic rings (280 nm), and phenolic groups (330 nm);
thus, analytical measurements were performed at these three
wavelengths. HPLC representative chromatograms of P.
madagascariensis extracts are available at the Supporting
Information (Figure S1). For each extract, the major peaks
were identified by comparing the retention time and UV−vis
spectrum overlay (Figure S2, Supporting Information) by co-
elution with pure standards. The peak eluted at 10.47 min,
which was present in all extracts, was positively identified as
rosmarinic acid (1, Figure 1) after co-elution with a
commercial standard (Figure S2, Supporting Information).
This polyphenol, found in several Plectranthus species, had
been previously identified in P. madagascariensis.5,33
The peaks obtained at the average retention times of 17.80,
19.40, and 19.80 min possessed the typical royleanone-type
abietane UV spectra25 (Figure S1, Supporting Information)
with an absorption maximum at 272 nm and a secondary broad
maximum between 300 and 500 nm, in accordance with other
phytochemical studies of Plectranthus species.32 The peaks at
17.80 and 19.80 min were identified as 6β,7α-dihydroxyr-
oyleanone (2, Figure 1) and 7α-acetoxy-6β-hydroxyroyleanone
(4, Figure 1), respectively, after co-elution of the extracts with
authentic samples previously obtained from Plectranthus spp.2
The peak at 19.40 min was identified as 7α-formyloxy-6β-
hydroxyroyleanone (3, Figure 1), isolated from the acetone
extract prepared by UAE, after co-elution with the purified
compound. A major peak eluted at 21.08 min showing a UV
spectrum (Figure S1, Supporting Information) comparable to
that of coleon U (5, Figure 1),23 a diterpene often found in
Plectranthus species, which was confirmed after co-elution of
the extracts with an authentic sample.2 This compound was
reported to have some intrinsic instability, being easily
converted to an oxidized form, coleon U-quinone (6, Figure
2).23,25 This degradation product was also detected in some P.
madagascariensis extracts as a trace at a retention time of 19.19
min. The periodic analysis of an authentic sample of (5)
revealed the gradual increase of the peak at 19.19 min and
concomitant reduction of the peak at 21.08 min, which
represents a gradual conversion of the compound (5) into its
oxidized form (6, Figure 2).
Isolation and Spectroscopic Structure Elucidation of
7α-Formyloxy-6β-hydroxyroyleanone (3). The compound
(3) was isolated from the acetone extract of P. madagascariensis
(480 mg of dried residue) prepared by UAE following column
chromatography using hexane/ethyl acetate 95:5 (v/v) as an
eluent and purified using preparative chromatography through
repeated elution with hexane/ethyl acetate 75:25 (v/v),
yielding 6.1 mg (1.27% (w/w) yield) of yellow needles after
recrystallization from methanol. The compound was fully
characterized using NMR spectroscopy (1H and 13C NMR
spectra available in the Supporting Information, Figures S3 and
S4, respectively).
The 1H NMR spectrum of (3) (Figure S3, Supporting
Information) was very similar to that of royleanone (4).29 The
main differences were due to the absence of the singlet signal
at δ 2.02 ppm corresponding to the methyl protons of the
acetoxyl group at C7 in (4) and the presence of a distinct
doublet at δ 8.05 ppm (J = 1.2 Hz), which might correspond to
an acidic proton from a secondary formyloxyl group.30 This
observation suggested the substitution of the 7α-acetoxyl
group of (4) by 7α-formyloxyl in (3), which was confirmed by
the literature30 and extensive NMR studies (1H and 13C NMR,
COSY, HMBC, and HMQC; Table 2). Thus, the compound
(3) was identified as 7α-formyloxy-6β-hydroxyroyleanone,
which has been previously isolated from Plectranthus
hadiensis31 and Plectranthus myrianthus.25 To our knowledge,
this was the first isolation of (3) from P. madagascariensis and
its first full 13C NMR characterization.
Kubińova ́ et al.5 have studied the methanol extract of P.
madagascariensis, which resulted in the identification of
rosmarinic acid (1), 6β,7α-dihydroxyroyleanone (2), 7α-
acetoxy-6β-hydroxyroyleanone (4), and coleon U-quinone
(6) as the major components of this extract. However, the
full spectroscopic elucidation of these compounds was not
accomplished by the authors.
The quantification of the major compounds in P.
madagascariensis extracts was also performed based on the
validated calibration curves for main polyphenol rosmarinic
acid (1) and main abietane diterpenes 6β,7α-dihydroxyroylea-
none (2), 7α-formyloxy-6β-hydroxyroyleanone (3), 7α-ace-
toxy-6β-hydroxyroyleanone (4), and coleon U (5). Linear
Figure 2. HPLC chromatogram showing the decomposition of coleon
U (5) to coleon U quinone (6).
Table 2. NMR Spectroscopic Data (400 MHz, CDCl3) for
7α-Formyloxy-6β-hydroxyroyleanone (3)
position δC, type δH (J in Hz) HMBC
1 38.49, CH2 1.19, s; 2.64, d (12.9)
2 19.09, CH2 1.50, m; 1.85, d (4.5)
3 42.45, CH2 1.20, 1.50, m
4 33.83, C
5 49.80, CH 1.38, s 10
6α 67.25, CH 4.37, m
7β 68.42, CH 5.80, m
8 136.45, C
9 150.38, C
10 38.79, C
11 183.34, C
12 151.13, C
13 124.35, C
14 183.34, C
15 24.34, CH 3.17, qi (14.1; 7.1) 13
16 33.85, CH3 1.24, d (7.1)
17 20.01, CH3 1.21, d (7.1) 13
18 33.57, CH3 0.96, s 3, 5, 19
19 23.97, CH3 1.25, s 3, 5, 18
20 21.71, CH3 1.62, s 1, 5
21 159.64, CH 8.04, d (1.2)
6-OH (1) 2.31, t (7.5)
12-OH (2) 7.20, m (3.1)
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responses and high sensitivity were obtained for all compounds
(Table S1, Supporting Information). The component yield in
each extract has been listed in Table 1.
7α-acetoxy-6β-hydroxyroyleanone (4) obtained from Plec-
tranthus grandidentatus is described to show strong in vitro
antiproliferative activity against several human cancer cell
lines,11 whereas taxodione from P. barbatus and their
semisynthetic derivatives were highly cytotoxic toward
human leukemia cells.19 Growth inhibition triggered by these
compounds was caused by induction of apoptosis, whereas cell
death was associated with the release of mitochondrial proteins
due to mitochondrial membrane depolarization.19 Addition-
ally, 7α-acetoxy-6β-hydroxyroyleanone (4) was identified as
the main compound that contributed to the cytotoxic activity
of the chloroform extract of P. amboinicus against breast cancer
MCF-7 cells, using an HPLC-based metabolomics approach.22
Rosmarinic acid (1) was the most abundant secondary
metabolite present in all extracts, with yields ranging from 4.60
to 50.5 mg/g (Table 1). This finding is in agreement with the
described abundance of this polyphenol in other Plectranthus
species.6,32 Coleon U (5) was diterpene quantified in higher
yields, although high yields of royleanone-type diterpenes (2−
4) were also found in all extracts, particularly in the acetone
ones (E1 and E2, Table 1).
Coleon U has been isolated from several Plectranthus
species, such as Plectranthus forsteri,23 P. grandidentatus,10,11
P. madagascariensis24 and P. myrianthus,25 exhibits potent
cytotoxic effects transversal to several human cancer cell lines,
including breast,11,19 lung,11 leukemia,10,19,26 and melano-
ma.11,19 Moreover, coleon U has been described as a potent
and selective activator of the proapoptotic protein kinases C-δ
(PKCδ) and C-ε (PKCε), which can be on the basis of its
reported antitumor action.27,28 However, coleon U is easily
degraded to its oxidized form, coleon U-quinone. This
metabolite has been isolated from Plectranthus xanthanthus
along with coleon U 11-acetate, and both showed cytotoxic
effects.23,26
Cytotoxicity Evaluation. The cytotoxic effects of P.
madagascariensis extracts have been previously evaluated in
the MDA-MB-231 cancer cell line by our group,24 and the
isolated abietane diterpenes most likely contribute to the
cytotoxicity of P. madagascariensis extracts. The extract
obtained by maceration with acetone (E2), which had the
highest combinatory yield of royleanone abietanes (Table 1),
was the most cytotoxic.24 The cytotoxic activities of the
royleanone diterpenes, that is, against breast cancer cell lines,
have been previously reported.11,19 Additionally, coleon U (5)
has been described in the literature as a potent cytotoxic agent,
being active against breast,11,19 leukemia,10,19,26 and melano-
ma11,19 cancer cell lines. However, the acetone extract (E1)
prepared by UAE and previously analyzed,24 which had the
highest yield of coleon U (5) and also the highest combinatory
yield of abietane diterpenes, was not the most cytotoxic. This
can be due to its higher amount of rosmarinic acid (1) because
the most cytotoxic extract (E2) had a lower yield of this
polyphenol compared to the other extracts (Table 1).
Rosmarinic acid (1) is known to be a potent antioxidant,6
and some studies related the cytotoxic effect of abietane
diterpenes possessing conjugated quinone moieties to the
induction of radical reactions,20,21 which may anticipate a
potential antagonistic effect between antioxidant polyphenols
and conjugated quinone diterpenes.
The cytotoxic activity of isolated compounds (1−5) from P.
madagascariensis extracts was assayed in breast cancer (MDA-
MB-231 and MCF-7), colon cancer (HCT116), non-small cell
lung cancer (NCI-H460), and normal lung bronchial (MCR-
5) cell lines (Table 3). Interestingly, in the MCF-7 cell line, the
structural modifications carried out in compounds (3−5)
significantly increased their antiproliferative effects when
compared to that in the compound 2 (Table 3). All abietane
diterpenes revealed growth inhibitory effects in most of the
cancer cell lines tested. Moreover, royleanones (2, 4) exhibited
high selectivity based on the comparison of GI50 for cancer
(NCI-H460) and normal lung (MCR-5) cell lines. These
royleanones also showed similar growth inhibition of the NCI-
H460 cancer cell line and its multidrug-resistant variant (NCI-
H460/R), which overexpress the multidrug resistance protein
1 (MDR1 or P-glycoprotein),34 suggesting that compounds (2,
4) are not substrates for such efflux pumps.
On the one hand, the growth of MDA-MB-231 cancer cells
was not particularly affected by abietane diterpenes. This cell
line is a highly metastatic triple negative breast cancer cell line
that does not display estrogenic receptors (ER), progesterone
receptors (PR), or human epidermal growth factor receptor 2
(HER2), thus being clinically difficult to target.35 The ER
negative cells are known to have a higher expression of PKC
classic isoforms when compared to ER positive cell lines.36 The
upregulation of the classic isoform PKCα promotes the
invasiveness and metastasis formation36 along with increased
drug resistance37 in breast cancers. On the other hand, the
PKCδ activation supports both prosurvival38 and proapop-
totic39 functions in breast cancer cells. Some abietane
diterpenes such as coleon U (5) have also been shown to
exert proapoptotic effects by the specific activation of PKC-δ
and PKC-ε.27,28 Therefore, in the MDA-MB-231 cell line
characterized by an overexpression of classic PKC isoforms in
detriment of new PKC isoforms, the preferential mechanism of
apoptosis induction by coleon U (and eventually by other
abietane diterpenes) through activation of PKC-δ and PKC-ε
should be less effective, which can explain the lower growth
inhibition of this cell line by these compounds.
Some relationships between the PKC overexpression and the
drug resistance by MDR1 have been reported. A cellular
increase of the MDR1 expression was verified following the
treatment with the PKC activator TPA, which was suppressed
by the use of a PKC inhibitor (staurosporine).40 Furthermore,
the use of the PKC inhibitor, bryostatin 1, potentiated the
cytotoxic effects of anticancer drugs transported by efflux
pumps, such as vincristine, by the reduction of MDR1
expression.41 Those findings can be especially relevant in the
case of abietane diterpenes being not transported by MDR1 for
which the PKC activation and the secondary MDR1
overexpression should not increase the cell resistance to such
compounds.
Structure−Activity Relationships. The obtained data on
abietane diterpene cytotoxicity (Table 3) combined with other
studies on the cytotoxicity of this class of compounds (Table
4) allowed the establishment of some structure−activity
relationships (SARs) for royleanone-type abietanes. The
main difference between royleanones (2) and (4) resides on
the polarity of the substituent at 7α (Figure 1). In this series, a
clear tendency was observed for increasing cytotoxicity with
the higher lipophilicity of the 7α substituent. The same
tendency was observed between horminone (Figure 3, R1 = H,
R2 = R3 = OH) and its more cytotoxic 7α-acetoxy derivative
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(Figure 3, R1 = H, R2 = OCOCH3, R3 = OH).
42,43 Whether
these structural alterations corresponded to an improved fitting
on the target or if the cytotoxic activity was instigated by
favorable log P for membrane crossing remains to be answered
because the cytotoxicity of several diterpenes has been
associated with a mechanism involving membrane-disrupting
properties.3,44
On the basis of the extensive literature reporting the
cytotoxicity on royleanone-type compounds bearing a p-
benzoquinone moiety in the ring C (Figure 3), additional
tendencies could be explored (Table 4).
Burmistrova et al.19 studied the cytotoxic effects for a series
of derivatives of 7α-acetoxy-6β-hydroxyroyleanone (4). The
overall compounds affect the cell proliferation with an
apparently cell-type dependent intensity. By displaying such
compounds by their log P value, a strong tendency for higher
cytotoxic effects was observed for log P values between 2 and
5.5. Because the “Lipinski rule of five” establishes that log P for
an oral bioavailable compound should be under 5, the useful
compounds must be considered in the 2−5 range of log P.45
The only exception for this trend was royleanone (Figure 3, R1
= R2 = H, R3 = OH) that showed only slight cytotoxic effects
in some cell lines.19,42,46 This could indicate that the presence
of a lipophilic substituent was required at positions 6 and/or 7
for the cytotoxic effects to take place. However, the 6,7-
dehydro derivative (Figure 3, R1 = R2 = HΔ,6,7 R3 = OH) has
shown some potent cell-type specific cytotoxic effects.47−49
Thus, the presence of an electron-donating group at position 6
or 7 seems to be essential for cytotoxic activity.
The cytotoxicity of the studied abietane diterpenes against
most of the cancer cell lines tested and the selectivity of the
royleanone-type compounds, particularly for non-small lung
cancer cells and their multidrug-resistant variant, encourage
further studies using this scaffold to develop analogues with
potential application as chemopreventive, chemoadjuvant, or
chemotherapeutic agents.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Chemical reagents
and standards were from Sigma-Aldrich and used as received.
Authentic samples of 7α,6β-dihydroxyroyleanone (2), 7α-
acetoxy-6β-hydroxyroyleanone (4), and coleon U (5) were
obtained from Gaspar-Marques.2 Solvents of either analytical
or HPLC grade were from Merck. Fetal bovine serum (FBS)
was from Gibco, penicillin−streptomycin for the cell culture
and an RPMI 1640 culture medium with ultraglutamine were
from Lonza, and Dulbecco’s modified Eagle’s medium
(DMEM) was from Biowest. Analytical TLC and preparative
TLC were performed on precoated silica gel plates from Merck
(Kieselgel 60 F254, 0.2 and 0.5 mm). For column
chromatography, silica gel 60 (0.063−0.200 mm) from
Merck was used. NMR spectra were recorded on a Varian
INOVA-400 spectrometer (Varian, Palo Alto, CA, USA)
equipped with a 5 mm inverse detection z-gradient probe. The
1H and 13C NMR spectra were acquired at 400 and 100 MHz,
respectively, using CDCl3 as the solvent, and the chemical
shifts were reported in parts per million referring to the
residual CHCl3 signal (δH 7.26 for proton and δC 77.0 for
carbon).
Cell Cultures. The human cell lines MDA-MB-231
(metastatic breast cancer), MCF-7 (estrogen-dependent breast
carcinoma), HCT116 (colorectal carcinoma), NCI-H460
(non-small cell lung carcinoma), and MCR-5 (normalT
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human embryonal bronchial epithelial cells) were obtained
from the American Type Culture Collection (ATCC, Rock-
ville, MD). The multidrug-resistant non-small cell lung
carcinoma cell line (NCI-H460/R) with P-glycoprotein
overexpression was obtained from the original NCI-H460
cell line by continuous treatment with stepwise increasing
concentrations of doxorubicin (5−100 nM) for 3 months
according to a procedure optimized by Pesic et al.34 Cell lines
were routinely cultured in RPMI 1640 with ultraglutamine or
DMEM (MDA-MB-231 cells), supplemented with 10% FBS,
100 U/mL penicillin, and 0.1 mg/mL streptomycin, and
maintained under standard cell conditions at 37 °C under a
humidified atmosphere containing 5% CO2.
50,51
Plant Material. Plectranthus madagascarensis Benth. was
cultivated in Parque Botan̂ico da Tapada da Ajuda (Instituto
Superior Agraŕio, Lisbon, Portugal) from cuttings obtained
from the Kirstenbosch National Botanical Garden (Cape
Town, South Africa), and voucher specimens (841/2007) were
deposited in the Herbarium Joaõ de Carvalho e Vasconcellos
(Instituto Superior Agraŕio, Lisbon, Portugal). The whole
plant material was collected in 2007, dried at room
temperature, and stored protected from light and humidity.
Extract Preparation. The dried plant was ground to small
pieces, pulverized, and extracted with acetone or methanol by
maceration (ME) or ultrasound-assisted extraction (UAE) and
also by supercritical fluid extraction (SCFE) with supercritical
CO2 (scCO2). Each crude extract was separated from the
remaining plant material by paper filtration, and the organic
solvents were evaporated in a rotary evaporator below 40 °C.
Each dried extract was weighted and stored at −20 °C until
further use.
The organic extracts were prepared by maceration (ME) or
ultrasound-assisted (UAE) extraction by adding the plant
material (10 g) to 200 mL of organic solvent (acetone or
methanol) kept stirring for 24 h (ME) or sonicated in an
ultrasonic bath at 35 kHz for 2 h (UAE). Alternatively,
supercritical fluid extraction (SCFE) was also performed by
packing the plant material (30 g) into a 278 cm3 inox cell and
injecting scCO2 during 3 h at a flow rate of 0.3 kg/h under a
pressure of 230 bar and a temperature of 40 °C.52 The
remaining plant material resulting from SCFE was recovered,
air dried, and re-extracted (R-SCFE) by addition to 200 mL of
acetone kept stirring for 24 h at room temperature.
Extraction and Purification of 7α-Formyloxy-6β-
hydroxyroyleanone (3). Ultrasound-assisted extraction of
P. madagascariensis by sonication of 100 g of plant material in 2
L of acetone for 2 h yielded 480 mg of dried residue (0.48%
(w/w) extraction yield) after evaporation of the organic
solvent. The extract was treated with activated charcoal to
eliminate the high content in chlorophyll plant pigments and
fractionated by chromatography on a silica gel (30 g) column
eluted with a gradient of ethyl acetate in hexane. The
compound (3) was recovered from the fraction eluted with
hexane/ethyl acetate 95:5 (v/v) and purified by preparative
chromatography through repeated elution with hexane/ethyl
acetate 75:25 (v/v) followed by recrystallization from
methanol, yielding 6.1 mg (1.27% (w/w) yield) of yellow
needles. Spectroscopic characterization was performed by one-
dimensional (1H and 13C NMR) and two-dimensional (COSY,
HMBC, and HSQC) NMR (Table 2 and Figures S3 and S4,
Supporting Information).
HPLC-DAD Fingerprinting. The extract profiling was
performed with an Agilent Technologies 1200 Infinity Series
LC system (Agilent Technologies, Santa Clara, CA, USA)
coupled to a diode array detector (DAD) and processed using
the ChemStation software. Four detection wavelengths were
selected: 254, 270, 280, and 330 nm. A 20 μL sample was
injected into a reverse phase LiChrospher 100 RP-18 5 μm
(4.0 × 250 mm) column (Merck, Darmstadt, Germany) and
eluted with a gradient composed of methanol (A), acetonitrile
(B), and 0.3% (w/v) trichloroacetic acid in ultrapure water
(C) as follows: 0 min, 15% A, 5% B, and 80% C; 20 min, 70%
A, 30% B, and 0% C; 25 min, 70% A, 30% B, and 0% C; and 28
min, 15% A, 5% B, and 80% C. The flow rate was set at 1 mL/
min at room temperature. Solvents were previously filtered and
degassed through a 0.22 μm membrane filter. All analysis was
performed in triplicate, and the results are presented as mean
± SD.
The major peaks from each extract sample were identified by
comparing the retention time and UV−vis spectrum overlay
with commercial standards (rosmarinic acid) or authentic
standards previously obtained from Plectranthus spp.2 The
calibration curves were constructed as a linear regression of the
analyte concentration (mM) against the average peak area. The
limit of detection (LOD) and limit of quantification (LOQ)
were determined to evaluate the sensitivity of the analysis
corresponding to the concentrations of the analyte that
resulted in signal-to-noise ratios of 3 (LOD) and 10 (LOQ)
following the guidelines from ICH Q2(R1) on validation of
analytical procedures.53 The LOD and LOQ were calculated as
LOD = 3.3σ/S and LOQ = 10σ/S, where σ corresponds to the
standard deviation of the response and S corresponds to the
slope of the calibration curve, which was estimated from the
calibration curve of the analyte (Table S1, Supporting
Information).
Cytotoxicity Assays. The cytotoxicity of compounds (1−
5) obtained from P. madagascariensis extracts was evaluated in
a battery of human cell lines (MDA-MB-231, MCF-7, and
HCT116) using the sulfurhodamine B (SRB) assay according
to a procedure supervised by Saraiva et al.54,55 Briefly, cells
were plated in 96-well plates (5.0 × 103 cells/well) and
incubated for 24 h at 37 °C in a humidified atmosphere with
5% CO2. Then, cells were exposed to serial dilutions of each
compound (1.85−150 μM) and incubated for another 48 h.
Following fixation with 10% trichloroacetic acid, cells were
stained with 0.4% (w/v) sulforhodamine B and then washed
with 1% acetic acid to remove the unbound stain. The
adsorbed dye was dissolved with 10 mM Tris buffer (pH 10.5),
and the absorbance was measured at 510 nm in a microplate
reader (Biotek Instruments Inc., Synergy MX, USA).
Doxorubicin was used as positive control. In Table 3, Student’s
t test was used to compare the GI50 values of compounds (3−
5) to that of compound 2 in the MCF-7 cell line. All P values
Figure 3. Proposed structure−activity relationships for 6,7,12-
substituted royleanone-type abietane diterpenes based on data from
Table 4.
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were based on the two-sided statistical analysis, and P < 0.05
was considered to be statistically significant.
The cytotoxic effects of the compounds toward NCI-H460,
NCI-H460/R, and MCR-5 cell lines were further assessed by
the MTT colorimetric assay based on the reduction of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) into a formazan dye by active mitochondria of living
cells according to the procedure described by Pesic et al.34,56
Briefly, cells were plated in 96-well plates, inoculated with the
compounds (2.5−50 μM), and incubated for 72 h at 37 °C in a
humidified atmosphere with 5% CO2. Then, 100 μL of MTT
solution (1 mg/mL) was added to each well, and the plates
were incubated at 37 °C for 4 h. The formazan product was
dissolved by adding 200 μL of DMSO per well, and
absorbance was measured at 540 nm in a microplate reader
(LKB 5060−006 Micro Plate Reader, Vienna, Austria).
Paclitaxel was used as positive control.
Cell viability (%) was calculated as a fraction of the
absorbance shown by nontreated cells (control), and the GI50
values, corresponding to the concentration of the compound
that inhibits 50% of cell growth, were determined. At least two
independent experiments in triplicate were performed for each
test compound. Statistical analysis was performed using
GraphPad Prism 6.01 (GraphPad Software Inc., La Jolla, CA,
USA). Results are presented as mean ± SD. Normality was
checked by Column Statistics of GraphPad Prism 6 software
Shapiro−Wilk normality test. Accordingly, the unpaired t test
from row data after the MTT measurement was applied.
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